BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paralta Branco F, Silva F, André S, Catarino A, Madureira R, Moreira Pinto J, Godinho J, Simões P, Freitas A, Casa-nova M, Nave M, Augusto J, Passos-coelho J. Loss of HER2 amplification and disease prognosis after neoadjuvant treatment of HER2 amplified breast cancer. European Journal of Cancer 2018;92:S94. [DOI: 10.1016/s0959-8049(18)30510-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Yu J, Li NL. Loss of human epidermal receptor-2 in human epidermal receptor-2+ breast cancer after neoadjuvant treatment: A case report. World J Clin Cases 2022; 10(17): 5923-5928 [DOI: 10.12998/wjcc.v10.i17.5923] [Reference Citation Analysis]